Docteur Glibert médecine physique et réadaptation
0712.733.531 · rovalta.com · 28/09/2026
Docteur Glibert médecine physique et réadaptation
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODocteur Glibert médecine physique et réadaptation is a Private limited company incorporated in 2018. Its main activity is: Specialist medical practice activities. Its registered office is in Court-Saint-Etienne.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0712.733.531
- Incorporation
- 30/10/2018
- Legal form
- Private limited company
- Registered office
- Drève des Chevreuils 10
1490 Court-Saint-Etienne · WallonieSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 7 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 144,1 k € | -4.9% | 151,4 k € | +10.0% | 137,7 k € | +16.1% | 118,6 k € | +126% | 52,6 k € |
| EBITDA | 142,6 k € | -5.5% | 150,9 k € | +9.8% | 137,4 k € | +16.3% | 118,1 k € | +127% | 52,1 k € |
| Operating result | 136,5 k € | -3.8% | 142 k € | +11.1% | 127,9 k € | +17.5% | 108,8 k € | +149% | 43,7 k € |
| Net result | 104,7 k € | -3.9% | 108,9 k € | +11.1% | 98,1 k € | +23.0% | 79,7 k € | +162% | 30,5 k € |
| Balance sheet | |||||||||
| Equity | 140,6 k € | -19.6% | 174,9 k € | +9.3% | 160 k € | -36.3% | 251,2 k € | +46.5% | 171,5 k € |
| Total assets | 290,5 k € | +4.0% | 279,3 k € | -25.6% | 375,2 k € | +39.3% | 269,3 k € | +30.9% | 205,7 k € |
| Cash | 290,5 k € | +6.3% | 273,3 k € | +2.0% | 267,9 k € | +15.6% | 231,7 k € | +39.6% | 166 k € |
| Debts | 149,9 k € | +43.5% | 104,4 k € | -51.5% | 215,2 k € | +1089% | 18,1 k € | -47.0% | 34,2 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Yumiko GLIBERT | Managersince 30/10/2018 |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
YumikoErica Glibert | Director |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/06/2026 | 28/08/2025 | 24/06/2024 | 28/08/2023 | 13/07/2022 | 27/08/2021 |
| General meeting | 31/05/2026 | 31/07/2025 | 31/05/2024 | 31/05/2023 | 31/05/2022 | 31/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 7 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 31/05/2026 | 29/06/2026 | Dutch | |
| Micro model | 31/12/2024 | 31/07/2025 | 28/08/2025 | French | |
| Micro model | 31/12/2023 | 31/05/2024 | 24/06/2024 | Dutch | |
| Micro model | 31/12/2022 | 31/05/2023 | 28/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 31/05/2022 | 13/07/2022 | Dutch | |
| Micro model | 31/12/2020 | 31/05/2021 | 27/08/2021 | French | |
| Micro model | 31/12/2019 | 02/06/2020 | 24/07/2020 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Yumiko GLIBERT | Managersince 30/10/2018 |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
YumikoErica Glibert | Director |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Drève des Chevreuils 10, 1490 Court-Saint-EtienneCurrent | CBE | |
| Avenue des Combattants 22 bte 203, 1340 Ottignies-Louvain-la-Neuve | accounts 2021 → 2025 | Accounts 2025 · 2026-00228347 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Docteur Glibert médecine physique et réadaptationCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00228347 |
Events
- 2025Annual accounts 2025104,7 k €↓
- 2024Annual accounts 2024108,9 k €↑
- 2023Annual accounts 202398,1 k €↑
- 2022Annual accounts 202279,7 k €↑
- 2021Annual accounts 202130,5 k €↓
- 2020Annual accounts 202092,3 k €↑
- 2019Annual accounts 201936,3 k €
- 30/10/2018IncorporationPrivate limited company